• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

IUD contraception equally safe in teenagers as in older women

bys25qthea
April 15, 2013
in Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD. Levonorgestrel molecule.

1. Overall, intrauterine devices had a very low rate of serious complications (<1%) in both teenagers and older women. 

2. Levonorgestrel-releasing intra-uterine device (IUD) was associated with fewer complications and less early discontinuation than the copper IUD in all age groups.  

Evidence Rating Level: 2 (Good) 

Study Rundown: The results of this study found that rates of serious IUD complications, including ectopic pregnancy and pelvic inflammatory disease (PID), were just as low (<1%) in teenagers as they were in older women. These findings suggest that the IUD is an effective, safe and appropriate means of contraception for women of all ages. Assessing outcomes only in insured women limits the generalizability of results. Strengths include a large size to assess rarely-occurring adverse events. Findings from this study support the use of one of the most highly effective forms of birth control available, long-acting reversible contraception via IUD, in our most vulnerable population.

Click to read the study in Obstetrics & Gynecology

Study author, Dr. Abbey B. Berenson, MD, PhD, talks to 2 Minute Medicine: Department of Obstetrics & Gynecology, University of Texas Medical Branch

RELATED REPORTS

Postpartum patients may be at an increased risk of intrauterine device-related perforation

Immediate postpartum intrauterine device insertion associated with increased risk of device expulsion: the APEX-IUD study

Associations between hormonal contraception and adverse health outcomes not supported by high-quality evidence

“Teenagers are at lower risk of having an unintended pregnancy when they use a long acting reversible method of contraception. This study showed that teenagers did not have more complications with one of the two IUDs currently available than adults and so it is appropriate to offer IUDs to teenagers.”

In Depth [retrospective cohort study]: The study used electronic health insurance claims from a nationwide U.S. private insurance company to evaluate complications in 90,489 women who received IUDs between 2002 and 2009. Outcomes evaluated include contraception failure, IUD removal within 1 year of insertion, and IUD complications such as pain, menstruation disorders, inflammation/infection, and uterine perforation. Multivariate logistic regression models stratified by age group (15-19 vs 20-24 vs 25-44 years) and type of IUD allowed for estimation of the effect of IUD type and age on outcomes.

The rate of serious complications (such as ectopic pregnancy or pelvic inflammatory disease) was <1% in all age groups. Results found that women aged 15-19 years old were more likely than women aged 25-44 to experience minor complications such as dysmenorrhea (odds ratio (OR):1.4, confidence interval (CI):1.1-1.6) and amenorrhea (OR:1.3, CI:1.1-1.5). Rates of early discontinuation were the same in both age groups (13% vs 11%, p>0.5), however a higher proportion of the copper IUD users who discontinued early were teenagers.

By Maren Shapiro and Leah Hawkins

More from this author: Black men less likely to receive follow-up for elevated prostate cancer marker, PSA,  More U.S. women using emergency contraception pill, No-cost contraception reduces unintended pregnancies 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: contraceptionIUDLevonorgestreluterine device
Previous Post

Home visits in Ghana improve neonatal mortality

Next Post

Significant racial disparities in preterm births in infants conceived by IVF

RelatedReports

AAP policy update recommends first-line contraceptives, addresses special populations
Emergency

Postpartum patients may be at an increased risk of intrauterine device-related perforation

June 15, 2022
Family planning providers use long acting contraception more than general population
Obstetrics

Immediate postpartum intrauterine device insertion associated with increased risk of device expulsion: the APEX-IUD study

February 28, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Obstetrics

Associations between hormonal contraception and adverse health outcomes not supported by high-quality evidence

January 21, 2022
1 in 5 US women report delayed contraceptive initiation after sexual debut
Chronic Disease

Improved contraception use with progestogen-only pill and rapid access vs emergency contraception

December 9, 2020
Next Post
Significant racial disparities in preterm births in infants conceived by IVF

Significant racial disparities in preterm births in infants conceived by IVF

One third of breast cancer survivors report pain 5-7 years after treatment

One third of breast cancer survivors report pain 5-7 years after treatment

Quality improvement methods increase adherence to pediatric pneumonia treatment guidelines

Quality improvement methods increase adherence to pediatric pneumonia treatment guidelines

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options